Measuring antianginal drug efficacy using exercise testing for chronic angina: Improved exercise peformance with ranolazine, a pFOX inhibitor
- 31 December 2002
- journal article
- Published by Elsevier BV in Current Problems in Cardiology
- Vol. 27 (12), 527-555
- https://doi.org/10.1016/s0146-2806(02)70007-8
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trialThe Lancet, 2000
- TrimetazidineDrugs, 1999
- Amlodipine versus nadolol in patients with stable angina pectorisAmerican Heart Journal, 1989
- Combined Beta-Adrenergic and Calcium-Entry Blockade in Angina PectorisNew England Journal of Medicine, 1989
- Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.Circulation, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Comparison of the antianginal effectiveness of nifedipine, verapamil, and isosorbide dinitrate in patients receiving propranolol: a double-blind study.Circulation, 1983
- The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study.Circulation, 1983
- Increased exercise tolerance and reduced electrocardiographic ischemia with diltiazem in patients with stable angina pectoris.Circulation, 1982
- Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible?Circulation, 1980